Croatia holds a presidential election with the incumbent NATO and EU critic considered favorite

Croatia holds a presidential election with the incumbent NATO and EU critic considered favorite


Croatian President and presidential candidate Zoran Milanovic votes at a polling station during the presidential election, in Zagreb, Croatia, on Dec. 29, 2024.

Antonio Bronic | Reuters

Croatia’s left-leaning president, an outspoken critic of Western military support for Ukraine in its war against Russia, is running for reelection in the Adriatic Sea state, but is unlikely to get an outright majority in the first round of voting on Sunday.

President Zoran Milanović, who is often compared to Donald Trump for his combative style of communication with political opponents, faces seven other contenders, including Dragan Primorac, the candidate of the ruling Croatian Democratic Union.

The two are expected to face off in the second round on Jan. 12 if no contender gets more than 50% of the vote, according to pre-election polls.

The most popular politician in Croatia, 58-year-old Milanović had served as prime minister in the past. Populist in style, Milanovic has been a fierce critic of current Prime Minister Andrej Plenković and continuous sparring between the two has lately marked Croatia’s political scene.

“Since the election silence is still on, I just want to call on people to get out and vote. To support me,” Milanović said after he voted on Sunday. He predicted there would be a second round in two weeks.

Plenković, the prime minister, has sought to portray the vote as one about Croatia’s future in the EU and NATO. He has labeled Milanović “pro-Russian” and a threat to Croatia’s international standing.

“The difference between him and Milanović is quite simple: Milanović is leading us East, Primorac is leading us West,” he said.

Though the presidency is largely ceremonial in Croatia, an elected president holds political authority and acts as the supreme commander of the military.

Milanović has criticized the NATO and European Union support for Ukraine and has often insisted that Croatia should not take sides. He has said Croatia should stay away from global disputes, thought it is a member of both NATO and the EU.

Milanović has also blocked Croatia’s participation in a NATO-led training mission for Ukraine, declaring that “no Croatian soldier will take part in somebody else’s war.”

His main rival in the election, Primorac, has stated that “Croatia’s place is in the West, not the East.” His presidency bid, however, has been marred by a high-level corruption case that landed Croatia’s health minister in jail last month and which featured prominently in pre-election debates.

During the election campaign, Primorac has sought to portray himself as a unifier and Milanović as divisive.

“Today is an extremely important day,” Primorac said after casting his ballot. “Croatia is going forward into the future. Croatia needs unity, Croatia needs its global positioning, and above all Croatia needs peaceful life.”

Trailing a distant third in the pre-election polls is Marija Selak Raspudić, a conservative independent candidate. She has focused her election campaign on the economic troubles of ordinary citizens, corruption and issues such as population decline in the country of some 3.8 million.

Sunday’s presidential election is Croatia’s third vote this year, following a snap parliamentary election in April and the European Parliament balloting in June.



Source

Investors are misreading news about the Iran war, analysts say as markets whipsaw
World

Investors are misreading news about the Iran war, analysts say as markets whipsaw

An Iranian flag flutters as a woman walks past damaged buildings amid a 10-day ceasefire between Lebanon and Israel, in the southern suburbs of Beirut, Lebanon, April 20, 2026. Marko Djurica | Reuters “Complacent” investors risk getting wrong-footed as they continue to misread developments in the Iran war, analysts said after markets reacted to the […]

Read More
Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to  billion
World

Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion

The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike Blake | Reuters Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, the company said Monday. Lilly will pay $3.25 billion upfront, and the remaining payments are contingent upon clinical, […]

Read More
USA Rare Earth to buy Brazil’s Serra Verde for .8 billion to build supply outside Asia
World

USA Rare Earth to buy Brazil’s Serra Verde for $2.8 billion to build supply outside Asia

USA Rare Earth has announced plans to buy Brazilian rare earths miner Serra Verde in a deal worth $2.8 billion in cash and shares, as it seeks to challenge China’s dominance of the supply chain. The Oklahoma-headquartered company said it will pay $300 million in cash and $126.9 million in its own newly issued stock […]

Read More